GSK3A and colorectal adenoma: Our team also demonstrated that the downregulation of RAS homolog family member A (RHOA) and glycogen synthase kinase 3 alpha (GSK3A) expression in plasma may function as a diagnostic biomarker of colorectal adenoma using a target sequencing approach [79].